Six Arizona bioscience startup firms have been competitively selected by the Flinn Foundation to participate in its 2018 Bioscience Entrepreneurship Program, receiving $30,000 each in funding support and program services…
bioSyntagma, LLC, a precision medicine company, has been awarded a National Science Foundation (NSF) Phase II Small Business Innovation Research (SBIR) grant of $735,139, to continue development of technology that can isolate…
Mayor Greg Stanton and the City Council unanimously approved funding to sponsor InnoVention, a new medical technology accelerator program through the University of Arizona on the Phoenix Biomedical Campus downtown—now one…
University of Arizona research activity topped $622 million in total research and development expenditures for fiscal 2017, surpassing the previous year’s total by more than $18 million. The UA’s total…
There’s no doubt that Millennials get a bad rap. Too many people view Millenials as a generation of foosball-in-the-office-playing, craft-beer-drinking, constant-affirmation-needing, selfie-stick wielding narcissists who have overinflated self-esteem because they…
With cooler weather, flu season and the stress that often comes with the holidays, illnesses are imminent this time of year. As a result, people are taking more pills but…
A group of the nation’s premier cancer researchers led by the Baylor Scott & White Research Institute (BSWRI) and the Translational Genomics Research Institute (TGen) — has secured a $5.13…
Jennifer Barton named director of UA’s BIO5 Institute Biomedical engineer Jennifer Kehlet Barton has been named director of the BIO5 Institute at the University of Arizona. The BIO5 Institute brings together researchers…
Abrazo Arizona Heart Hospital has opened its new Institute for Congestive Heart Failure that is being touted as one of the nation’s first of its kind for its comprehensive, patient-centered…
A University of Arizona College of Medicine – Phoenix researcher has received a $2.3 million grant from the National Institutes of Health to develop new treatments for depression. Deveroux Ferguson,…
DxNA LLC, a molecular diagnostics company, today announced the regulatory clearance by the U.S. Food and Drug Administration (FDA) to market its molecular test for rapid detection of Coccidioidomycosis (Valley…
Arizona State University (ASU) has joined a national initiative that brings patients, researchers, health systems and clinicians together to help people make informed healthcare decisions and improve healthcare delivery and…
